Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. The Company develops nanoparticle technology to target autoimmune and inflammatory diseases through the induction of antigen specific immune tolerance in the liver.